
The GMO Beyond China ETF seeks to deliver total return by investing primarily in equities of companies GMO believes are positioned to benefit, directly or indirectly, from the expected trend of companies diversifying their supply chains. We believe this secular trend is an attractive investment opportunity driven by a combination of increasing labor costs in China, increasing geopolitical tensions, and increasing focus on supply chain diversification. The GMO Beyond China ETF will primarily invest in emerging market equities with the exception of Chinese securities. GMO uses a combination of…
Is BCHI's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

The global economic landscape is shifting in 2025. Investors are navigating a complex environment shaped by geopolitical tensions, trade uncertainties, and evolving market dynamics.

In response to the ongoing turbulence in global trade and rising tensions surrounding tariffs, GMO has unveiled a new ETF listed on the NYSE Arca — the GMO Beyond China ETF (BCHI). This fund aims to provide investors with an innovative way to navigate the evolving economic landscape.

BOSTON--(BUSINESS WIRE)--GMO launches actively-managed GMO Beyond China ETF (BCHI), designed to capitalize on the significant shift in global supply chains away from China.